Below are the financial statements of Vaxcyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in thousands of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating expenses | — | — | — |
| Research and development | -476,644a | -332,341a | -169,451a |
| Acquired manufacturing rights | 0a | -75,000a | -22,995a |
| General and administrative | -92,902a | -60,700a | -39,810a |
| Total operating expenses | -569,546a | -468,041a | -232,256a |
| Loss from operations | -569,546a | -468,041a | -232,256a |
| Other income (expense), net | — | — | — |
| Interest expense | 0a | 0a | -2a |
| Interest income | 109,994a | 62,907a | 8,356a |
| Other income (expense) | -4,375a | 2,868a | 417a |
| Total other income, net | 105,619a | 65,775a | 8,771a |
| Net loss | -463,927a | -402,266a | -223,485a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vaxcyte’s data sources below and access millions more through our Disclosure Search.